Derma Cosmetics Gain Momentum in Post-Pandemic Korea
With the COVID-19 pandemic transitioning into an endemic in Korea, and the outdoor mask mandate lifted, the cosmetics industry is seeing a recovery in sales. Derma Cosmetics, a blend of "Dermatology" and "Cosmetics", is emerging as a leading trend. These products combine the core ingredients of pharmaceuticals with cosmetics, offering an accessible solution for skincare.
Pharmaceutical Companies Pioneering in Derma Cosmetics
Several pharmaceutical companies are making strides in this sector. A notable example is Dongkook Pharm, which has introduced various successful brands such as Centellian24, Madeca21, MadecaDerma, and Kipra.
Madeca Cream, developed using Madeca Sol, a wound treatment ointment, has reached remarkable sales of 31 million since 2015. Centellian 24's hit product, "Expert Madeeca Melacapture ampoule", has also achieved cumulative sales of 10 million bottles.
DongWha Pharm launched "Fusid Cream", a cosmetic adaptation of the popular Korean wound ointment "Fusidin". With 38.9% of "Fusiderm" included in the formula to improve skin density, the product has garnered cumulative sales of 10 billion won and sold 770,000 units so far.
The Future of Derma Cosmetics Market
Brands like "Fation" from DongA Pharm, "Wellage" from Hugel, and "Neuraderm" from Medytox are also claiming their share in Korea's cosmetics market. According to P&S Intelligence, the global Derma Cosmetics market is forecasted to grow to a staggering $115 billion by 2030.
Citation
(1*) Dongkook Pharm (dkbrand.co.kr)(2*) NewsWay Article (newsway.co.kr)
(3*) Dong-Wha Pharma (dong-wha.co.kr)
(4*) P&S Market Research (psmarketresearch.com)
(5*) Tags/Labels: Derma Cosmetics in Korea, Pharmaceutical Companies in Cosmetics, (6*) Global Derma Cosmetics Market, Korean Skincare, Cosmetic Industry Trends
Comments
Post a Comment